Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Multilabel Microplate Reader

October 31, 2011 8:04 am | Product Releases | Comments

LabLogic Systems has released its Chameleon V multilabel microplate reader for researchers using fluorescence and luminescence for bio-analysis.


RNA Isolation Kit

October 31, 2011 7:50 am | Drug Discovery & Development | Product Releases | Comments

G-Biosciences' GET Total RNA Kit isolates total RNA from contaminating DNA, proteins, and nucleases in under 60 minutes using a simple three step protocol. The kit is compatible with numerous species and tissues.


MonoSol Amends Lawsuit Against BioDelivery

October 31, 2011 7:36 am | News | Comments

MonoSol Rx, LLC, the developer of PharmFilm drug delivery technology, announced that it has filed a second amended complaint in its litigation against BioDelivery Sciences International, Inc. and its development partners.


Study Creates Tool for Cancer Drug Development

October 31, 2011 7:29 am | News | Comments

Scientists have cataloged and cross-indexed the actions of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes critical for cancer and other diseases.


Revalesio Presenting RNS60 Data at ACAAI

October 31, 2011 7:15 am | News | Comments

RNS60 demonstrated therapeutic benefit and proved safe at all dose levels. In a multi-dose stage of the Phase 1 study, RNS60 significantly improved peak flows and quality of life scores in patients diagnosed with stable, mild to moderate asthma.


Gilead Submits Quad NDA

October 31, 2011 7:10 am | News | Comments

Gilead Sciences, Inc. announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for marketing approval of the "Quad", a complete single-tablet regimen for the treatment of HIV-1 infection in adults.


Pfizer to Report 3Q Results

October 31, 2011 6:56 am | News | Comments

Pfizer Inc. will discuss a few recent drug approvals, others that could get approved in the next year or two, and what will happen when Lipitor, which accounts for about one-fifth of its revenue, gets generic competition.


Court Blocks Generic Lovenox from Being Sold

October 31, 2011 6:30 am | News | Comments

Momenta Pharmaceuticals Inc. won a federal court ruling that temporarily blocks other companies from selling a generic version of its anti-clotting drug.


President Orders FDA to Reduce Drug Shortages

October 31, 2011 6:18 am | by Jim Kuhnhenn | News | Comments

President Barack Obama is directing the Food and Drug Administration to take steps to reduce drug shortages, an escalating problem that has endangered patients and raised the possibility of price gouging.


Researchers Define Faster, Cheaper Manufacturing Process for Heparin

October 28, 2011 12:47 pm | News | Comments

Researchers have developed a process to manufacture molecular weight heparin and produce a drug identical in performance and safety to the current anticoagulant fondaparinux.


FDA Extends Action Date for Dapagliflozin

October 28, 2011 12:41 pm | News | Comments

Bristol-Myers Squibb and AstraZeneca announced that the U.S. Food and Drug Administration has extended the action date for dapagliflozin for the treatment of Type 2 diabetes.


Eli Lilly Foundation Commits $30 Million to TB Study

October 28, 2011 12:38 pm | News | Comments

The Eli Lilly and Company Foundation has committed $30 million in funding to further support The Lilly MDR-TB Partnership in its fight against multidrug-resistant tuberculosis.


Etanercept Reduces TRAPS Symptons

October 28, 2011 12:34 pm | News | Comments

A study shows that the medication, etanercept, reduces the frequency and severity of symptoms of TNF receptor-associated periodic syndrome.


Electronic Data Capture Software

October 28, 2011 12:31 pm | Drug Discovery & Development | Product Releases | Comments

BioClinica Inc.’s Express EDC is a web-based platform of an electronic data capture solution for clinical trial processes.


Pharmacovigilance Analytics Software

October 28, 2011 12:23 pm | Product Releases | Comments

Oracle Health Sciences’ Pharmacovigilance Operational Analytics provides a 360-degree view of a safety organization's case processing operations.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.